Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is giving a ...

On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated ...

During a live event, Binod Dhakal, MD, discussed the evidence for targeting XPO1 and GPRC5D before BCMA CAR T-cell therapy in multiple myeloma.

Scientists say stem cell transplantation is often the only potential cure for some highly aggressive types of blood cancer ...

THIS INSIGHTFUL educational session, titled ‘Neurologic complications across immunotherapies – a comparative perspective’, ...

First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline –– Announced FDA Approval of VEPPANU™ ...

Climb Bio Inc.’s stock-tickling event May 5 highlighting Fc-enhanced monoclonal antibody (mAb) budoprutug, followed two days later by a financial update, has kept Wall Street buzzing. Mizuho analyst ...

THE 52ND ANNUAL Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held in the highest-altitude ...

We are excited to discuss encouraging initial safety data from the first participant in our Phase 1/2 clinical trial of ...

NEW YORK – Curocell and ProBio, which provides cell therapy manufacturing support to biotechs, say they're one step closer to treating lymphoma patients in South Korea with the autologous ...

The table below is a review of notable updates that occurred in April 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.